Hanne M Frøyshov1,2, Åshild Bjørnerem3, Torgeir Engstad4,5, Dag Seeger Halvorsen5,6. 1. Department of Internal Medicine, University Hospital of North Norway, Harstad, Norway. hanne.froyshov@unn.no. 2. Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway. hanne.froyshov@unn.no. 3. Department of Health and Care Sciences, UiT The Arctic University of Norway, Tromsø, Norway. 4. Department of Geriatric Medicine, University Hospital of North Norway, Tromsø, Norway. 5. Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway. 6. Department of Internal Medicine, University Hospital of North Norway, Tromsø, Norway.
Abstract
BACKGROUND AND AIMS: High levels of inflammatory markers shortly after an ischemic stroke are associated with a worse prognosis. Whether inflammatory markers predict long-term mortality in stroke-survivors is less clear. We examined whether a persisting inflammatory response (levels of inflammatory markers >1 year after the stroke event) was associated with long-term mortality. METHODS: We recruited participants from the Tromsø Study, Norway, in a nested case-control design. At baseline in 1997, white blood cell count (WBC), serum levels of fibrinogen, interleukin 6 (IL-6) and high sensitive C-reactive protein (hs-CRP) were analysed in 187 stroke-survivors, a median of 7.0 years (range 1-43) after the first-ever ischemic stroke, and in 243 stroke-free subjects. Cox proportional hazard regression model was used to examine whether inflammatory markers predicted all-cause mortality in both groups from 1997 to 2013. RESULTS: During an average of 16 years follow-up, 117 (62.5 %) stroke-survivors and 107 (44.0 %) stroke-free subjects deceased (p for differences 0.005). In stroke-survivors, fibrinogen and log IL-6 predicted all-cause mortality after adjustment for age, sex, BMI, smoking, Frenchay activity index, comorbidity and use of statins (HRs 1.26; 9 5 % CI 1.05-1.51 and 2.02; 95 % CI 1.12-3.64, respectively). In stroke-free subjects log hs-CRP predicted all-cause mortality after additionally accounting for levels of cholesterol, blood pressure and use of blood pressure lowering drugs (HR 1.95; 95 % CI 1.26-2.99). CONCLUSIONS: Fibrinogen and IL-6 were independent predictors of mortality in long-term stroke-survivors, whereas elevated hs-CRP predicted mortality in stroke-free subjects. Mortality risk prediction in stroke-survivors differed from that of stroke-free subjects.
BACKGROUND AND AIMS: High levels of inflammatory markers shortly after an ischemic stroke are associated with a worse prognosis. Whether inflammatory markers predict long-term mortality in stroke-survivors is less clear. We examined whether a persisting inflammatory response (levels of inflammatory markers >1 year after the stroke event) was associated with long-term mortality. METHODS: We recruited participants from the Tromsø Study, Norway, in a nested case-control design. At baseline in 1997, white blood cell count (WBC), serum levels of fibrinogen, interleukin 6 (IL-6) and high sensitive C-reactive protein (hs-CRP) were analysed in 187 stroke-survivors, a median of 7.0 years (range 1-43) after the first-ever ischemic stroke, and in 243 stroke-free subjects. Cox proportional hazard regression model was used to examine whether inflammatory markers predicted all-cause mortality in both groups from 1997 to 2013. RESULTS: During an average of 16 years follow-up, 117 (62.5 %) stroke-survivors and 107 (44.0 %) stroke-free subjects deceased (p for differences 0.005). In stroke-survivors, fibrinogen and log IL-6 predicted all-cause mortality after adjustment for age, sex, BMI, smoking, Frenchay activity index, comorbidity and use of statins (HRs 1.26; 9 5 % CI 1.05-1.51 and 2.02; 95 % CI 1.12-3.64, respectively). In stroke-free subjects log hs-CRP predicted all-cause mortality after additionally accounting for levels of cholesterol, blood pressure and use of blood pressure lowering drugs (HR 1.95; 95 % CI 1.26-2.99). CONCLUSIONS:Fibrinogen and IL-6 were independent predictors of mortality in long-term stroke-survivors, whereas elevated hs-CRP predicted mortality in stroke-free subjects. Mortality risk prediction in stroke-survivors differed from that of stroke-free subjects.
Entities:
Keywords:
CRP; High sensitive-CRP; Inflammatory markers; Interleukin-6; Mortality; Stroke
Authors: William M Armstead; Hugh Hekierski; Philip Pastor; Serge Yarovoi; Abd Al-Roof Higazi; Douglas B Cines Journal: Transl Stroke Res Date: 2018-02-23 Impact factor: 6.829
Authors: Ana Maria Baptista Menezes; Paula Duarte Oliveira; Fernando César Wehrmeister; Helen Gonçalves; Maria Cecilia F Assunção; Luciana Tovo-Rodrigues; Gustavo Dias Ferreira; Isabel O Oliveira Journal: Cytokine Date: 2018-04-25 Impact factor: 3.861
Authors: Ana Maria Baptista Menezes; Paula Duarte Oliveira; Fernando César Wehrmeister; Maria Cecilia F Assunção; Isabel O Oliveira; Luciana Tovo-Rodrigues; Gustavo Dias Ferreira; Helen Gonçalves Journal: PLoS One Date: 2019-05-09 Impact factor: 3.240